Health and Fitness Health and Fitness
Fri, October 14, 2011
[ Fri, Oct 14th 2011 ] - Market Wire
00 AM ET
[ Fri, Oct 14th 2011 ] - Market Wire
Real-Time Bandwidth Monitor
Thu, October 13, 2011

Incyte to Report Third Quarter 2011 Financial Results and Provide Update on Key Clinical Programs on October 27


Published on 2011-10-13 13:26:14 - Market Wire
  Print publication without navigation


WILMINGTON, Del.--([ BUSINESS WIRE ])--Incyte Corporation (Nasdaq: INCY) announced today that it has scheduled its third quarter 2011 financial results conference call for 8:30 a.m. ET on Thursday, October 27, 2011. The schedules for the press release and conference call are as follows:

-- Q3 2011 Press Release: October 27, 2011 at 7:00 a.m. ET
-- Q3 2011 Conference Call: October 27, 2011 at 8:30 a.m. ET
-- Domestic Dial In Number: 877-407-8037
-- International Dial In Number: 201-689-8037
-- Conference ID # 380549

If you are unable to participate, a replay of the conference call will be available for thirty days. The replay dial-in number for the U.S. is 877-660-6853 and dial-in number for international callers is 201-612-7415. To access the replay you will need the conference account number 278 and the ID number 380549.

The conference call will also be webcast live and can be accessed at [ www.incyte.com ] under Investor Relations, Events and Webcasts.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based drug discovery and development company focused on developing proprietary small molecule drugs for oncology and inflammation. For additional information on Incyte, visit the Company's web site at [ www.incyte.com ].